Survival analysis demonstrated that high expression of HMGCS1, HMGCR, and IDI1 was associated with poor prognosis in SCLC patients, while the expression of FDFT1 and SQLE did not significantly impact patient outcomes (P > 0.05) (Figure 6B). This evidence concerns the gene FDFT1 and small cell lung carcinoma.